MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer

References

• Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2016;3:524.
   Web of Science ®Google Scholar
• Micke P, Faldum A, Metz T, Beeh KM, Bittinger F, Hengstler JG, Buhl R. Staging small cell lung cancer: veterans administration lung study group versus international association for the study of lung cancer–what limits limited disease? Lung Cancer. 2002;37(3):271–276.
   PubMed Web of Science ®Google Scholar
• Kim YH, Mishima M. Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev. 2011; 37(2):143–150. doi:10.1016/j.ctrv.2010.05.004.
   PubMed Web of Science ®Google Scholar
• Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI, Choy H. Primary analysis of a phase II randomized trial radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011; 81(1):77–84. doi:10.1016/j.ijrobp.2010.05.013.
   PubMed Web of Science ®Google Scholar
• Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Ew Y. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol. 2003; 21(8):1544–1549. doi:10.1200/JCO.2003.10.089.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Ren J, Chen Y, Song H, Chen L, Wang R. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line. J Cell Biochem. 2013; 114(6):1395–1403. doi:10.1002/jcb.24481.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009; 49(5):1571–1582. doi:10.1002/hep.22806.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang P, Sun X, Sun Y, Shi C, Liu H, Liu X. MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells. Int J Oncol. 2015; 47(4):1379–1392. doi:10.3892/ijo.2015.3144.
   PubMed Web of Science ®Google Scholar
• Kundu ST, Byers LA, Peng DH, Roybal JD, Diao L, Wang J, Tong P, Creighton CJ, Dl G. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene. 2016; 35(2):173–186. doi:10.1038/onc.2015.71.
   PubMed Web of Science ®Google Scholar
• Singh R, Shankar BS, Kb S. TGF-beta1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells. Cell Signal. 2014; 26(7):1604–1615. doi:10.1016/j.cellsig.2014.03.028.
   PubMed Web of Science ®Google Scholar
• Skalamera D, Dahmer-Heath M, Stevenson AJ, Pinto C, Shah ET, Daignault SM, Said NA, Davis M, Haass NK, Williams ED, et al. Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer. Oncotarget. 2016; 7(38):61000–61020. doi:10.18632/oncotarget.11314.
   PubMedGoogle Scholar
• Rastogi I, Rajanna S, Webb A, Chhabra G, Foster B, Webb B, Puri N. Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer. Biochem Biophys Res Commun. 2016; 477(4):937–944. doi:10.1016/j.bbrc.2016.07.003.
   PubMed Web of Science ®Google Scholar
• Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One. 2014; 9(9):e107514. doi:10.1371/journal.pone.0107514.
   PubMed Web of Science ®Google Scholar
• Ito T, Kudoh S, Ichimura T, Fujino K, Hassan WA, Udaka N. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1. Hum Cell. 2017; 30(1):1–10. doi:10.1007/s13577-016-0149-3.
   PubMed Web of Science ®Google Scholar
• Liu X. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I. Cell Motil Cytoskeleton. 2008; 65(12):935–944. doi:10.1002/cm.20315.
   PubMed Web of Science ®Google Scholar
• Rafei H, El-Bahesh E, Finianos A, Nassereddine S, Tabbara I. Immune-based therapies for non-small cell lung cancer. Anticancer Res. 2017; 37(2):377–387. doi:10.21873/anticanres.11330.
   PubMed Web of Science ®Google Scholar
• Osho AA, Azzoli CJ, Pai S, Mino-Kenudson M, Faquin WC, Huynh TG, Lanuti M, Mathisen DJ, Muniappan A. Successful treatment of an aggressive tracheal malignancy with immunotherapy. Ann Thorac Surg. 2017;103(2): e123-e125. doi:10.1016/j.athoracsur.2016.08.021.
   Web of Science ®Google Scholar
• Sun CC, Li SJ, Zhang F, Zhang YD, Zuo ZY, Xi YY, Wang L, Dj L. The novel miR-9600 suppresses tumor progression and promotes paclitaxel sensitivity in non-small-cell lung cancer through altering STAT3 expression. Mol Ther Nucleic Acids. 2016; 5:e387. doi:10.1038/mtna.2016.96.
   PubMedGoogle Scholar
• Borzi C, Calzolari L, Centonze G, Milione M, Sozzi G, Fortunato O. mir-660-p53-mir-486 network: A new key regulatory pathway in lung tumorigenesis. Int J Mol Sci. 2017;18(1): doi:10.3390/ijms18010222.
   PubMed Web of Science ®Google Scholar
• Wang L, Yao J, Sun H, He K, Tong D, Song T, Huang C. MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. Oncol Lett. 2017; 13(1):329–338. doi:10.3892/ol.2016.5423.
   PubMed Web of Science ®Google Scholar
• Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Sy X. MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther. 2017; doi: 10.1080/15384047.2017.1281497.
   Web of Science ®Google Scholar
• Cao J, Song Y, Bi N, Shen J, Liu W, Fan J, Sun G, Tong T, He J, Shi Y, et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res. 2013; 73(11):3326–3335. doi:10.1158/0008-5472.CAN-12-3055.
   PubMed Web of Science ®Google Scholar
• Alvarado-Luna G, Morales-Espinosa D. Treatment for small cell lung cancer, where are we now?-a review. Transl Lung Cancer Res. 2016; 5(1):26–38. doi:10.3978/j.issn.2218-6751.2016.01.13.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Heymach JV, Sm L. Lung cancer. N Engl J Med. 2008; 359(13):1367–1380. doi:10.1056/NEJMra0802714.
   PubMed Web of Science ®Google Scholar
• Jansson MD, Ah L. MicroRNA and cancer. Mol Oncol. 2012; 6(6):590–610. doi:10.1016/j.molonc.2012.09.006.
   PubMed Web of Science ®Google Scholar
• Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, Shakibaei M, Boland CR, Goel A. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis. 2015; 36(3):355–367. doi:10.1093/carcin/bgv006.
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442–454. doi:10.1038/nrc822.
   PubMed Web of Science ®Google Scholar
• Puppo M, Bucci G, Rossi M, Giovarelli M, Bordo D, Moshiri A, Gorlero F, Gherzi R, Briata P. miRNA-mediated khsrp silencing rewires distinct post-transcriptional programs during tgf-beta-induced epithelial-to-mesenchymal transition. Cell Rep. 2016; 16(4):967–978. doi:10.1016/j.celrep.2016.06.055.
   PubMed Web of Science ®Google Scholar
• Cespedes MV, Casanova I, Parreno M, Mangues R. Mouse models in oncogenesis and cancer therapy. Clin Transl Oncol. 2006;8(5):318–329.
   PubMedGoogle Scholar